Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice - PubMed (original) (raw)
. 2001 Nov;299(2):659-65.
Affiliations
- PMID: 11602679
Confluence of antianalgesic action of diverse agents through brain interleukin(1beta) in mice
J J Rady et al. J Pharmacol Exp Ther. 2001 Nov.
Abstract
Spinal dynorphin A(1-17) (Dyn) has been shown previously to produce an antianalgesic action against intrathecal morphine in the tail-flick test in CD-1 mice. This action is known to be mediated indirectly from the spinal cord through an afferent pathway that activates flumazenil-sensitive benzodiazepine receptors in the brain and a descending circuit back down to the spinal cord sequentially involving cholecystokinin, leu-enkephalin, and N-methyl-D-aspartate receptors to produce antianalgesia. Interleukin (IL)-1beta is also known to act on peripheral afferent nerves to the brain to activate a descending circuit to release spinal cholecystokinin. The present investigation determined whether IL1beta is a supraspinal mediator for intrathecal Dyn-induced antianalgesia in CD-1 mice. Intracerebroventricular Lys193-D-Pro-Thr195, an IL1beta antagonist, or pretreatment with IL1beta antiserum eliminated intrathecal dynorphin antianalgesia, implicating brain IL1beta; 10 ng of IL(1beta) given intracerebroventricularly produced antianalgesia. Fittingly, Dyn was not antianalgesic in C3H/HeJ mice, which are genetically deficient in release of IL1beta. Activation of central benzodiazepine receptors preceded the IL1beta step because flumazenil inhibited Dyn but not IL1beta antianalgesia. On the other hand, [1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide], an antagonist for peripheral benzodiazepine receptors that have also recently been detected in brain tissue, inhibited IL1beta antianalgesia; these latter benzodiazepine receptors formed a separate step after the flumazenil-sensitive benzodiazepine receptor step. IL1beta action in the brain was linked to the linear steps in the spinal cord (cholecystokinin/N-methyl-D-aspartate receptors) as shown by inhibition with appropriate antagonists. Thus, IL1beta is a central physiological mediator in the antianalgesic action evoked by spinal dynorphin.
Similar articles
- Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
Rady JJ, Holmes BB, Fujimoto JM. Rady JJ, et al. Pharmacol Biochem Behav. 1998 May;60(1):245-54. doi: 10.1016/s0091-3057(97)00578-9. Pharmacol Biochem Behav. 1998. PMID: 9610949 - Nociceptin and dynorphin A(1-17) produce antianalgesia through independent systems in mice.
Rady JJ, Fujimoto JM. Rady JJ, et al. Life Sci. 2002 Jan 18;70(9):1085-93. doi: 10.1016/s0024-3205(01)01471-0. Life Sci. 2002. PMID: 11860156 - Dynorphinergic mechanism mediating endomorphin-2-induced antianalgesia in the mouse spinal cord.
Wu HE, Sun HS, Darpolar M, Leitermann RJ, Kampine JP, Tseng LF. Wu HE, et al. J Pharmacol Exp Ther. 2003 Dec;307(3):1135-41. doi: 10.1124/jpet.103.056242. Epub 2003 Oct 13. J Pharmacol Exp Ther. 2003. PMID: 14557378 - Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
Rady JJ, Holmes BB, Tseng LF, Fujimoto JM. Rady JJ, et al. J Pharmacol Exp Ther. 2001 May;297(2):582-9. J Pharmacol Exp Ther. 2001. PMID: 11303046 - Antianalgesic action of nociceptin originating in the brain is mediated by spinal prostaglandin E(2) in mice.
Rady JJ, Campbell WB, Fujimoto JM. Rady JJ, et al. J Pharmacol Exp Ther. 2001 Jan;296(1):7-14. J Pharmacol Exp Ther. 2001. PMID: 11123356
Cited by
- Inflammation-induced shift in the valence of spinal GABA-A receptor-mediated modulation of nociception in the adult rat.
Anseloni VC, Gold MS. Anseloni VC, et al. J Pain. 2008 Aug;9(8):732-8. doi: 10.1016/j.jpain.2008.03.004. Epub 2008 May 7. J Pain. 2008. PMID: 18467182 Free PMC article. - Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, Hughes TS, Landgraf KE, Chan S, Fong S, Phipps S, Falke JJ, Leinwand LA, Maier SF, Yin H, Rice KC, Watkins LR. Hutchinson MR, et al. Brain Behav Immun. 2010 Jan;24(1):83-95. doi: 10.1016/j.bbi.2009.08.004. Epub 2009 Aug 11. Brain Behav Immun. 2010. PMID: 19679181 Free PMC article. - The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.
Raghavendra V, Rutkowski MD, DeLeo JA. Raghavendra V, et al. J Neurosci. 2002 Nov 15;22(22):9980-9. doi: 10.1523/JNEUROSCI.22-22-09980.2002. J Neurosci. 2002. PMID: 12427855 Free PMC article. - The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats.
Kwiatkowski K, Piotrowska A, Rojewska E, Makuch W, Mika J. Kwiatkowski K, et al. J Neuroimmune Pharmacol. 2017 Sep;12(3):402-419. doi: 10.1007/s11481-017-9729-6. Epub 2017 Mar 23. J Neuroimmune Pharmacol. 2017. PMID: 28337574 Free PMC article. - Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain.
Apkarian AV, Lavarello S, Randolf A, Berra HH, Chialvo DR, Besedovsky HO, del Rey A. Apkarian AV, et al. Neurosci Lett. 2006 Oct 23;407(2):176-81. doi: 10.1016/j.neulet.2006.08.034. Epub 2006 Sep 14. Neurosci Lett. 2006. PMID: 16973269 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources